ASEAN Cancer Targeted Therapy Market Report Outlook (2021–2031)
The ASEAN Cancer Targeted Therapy Market size is expected to reach US$ 9,217.7 million by 2031 from US$ 3,422.2 million in 2024. The market is estimated to record a CAGR of 15.2% from 2025 to 2031.
Report Coverage
- Therapy Type: Monoclonal Antibodies, Tyrosine Kinase Inhibitors, Immune Checkpoint Inhibitors, Cancer Vaccines, Gene Therapy, Other Therapy Types
- Indication: Blood Cancer, Lung Cancer, Breast Cancer, Colorectum Cancer, Prostate Cancer, Stomach Cancer, Cervical Cancer, Liver and Intrahepatic Bile Duct Cancer, Thyroid Cancer, Other Indications
- End User: Hospital Pharmacies, Retail Pharmacies, Online Stores
US$ 3,422.2 Mn
Market size in 2024
US$ 9,217.7 Mn
Market Size by 2031
15.2%
CAGR, 2025 - 2031
2025-2031
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. ASEAN Cancer Targeted Therapy Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. ASEAN Cancer Targeted Therapy Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. ASEAN Cancer Targeted Therapy Market Regional Analysis
6.2 ASEAN Cancer Targeted Therapy Market Revenue 2021-2031 (US$ Million)
6.3 ASEAN Cancer Targeted Therapy Market Forecast Analysis
7. ASEAN Cancer Targeted Therapy Market Analysis – by Therapy Type
7.1 Monoclonal Antibodies
- 7.1.1 Overview
- 7.1.2 Monoclonal Antibodies: ASEAN Cancer Targeted Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Tyrosine Kinase Inhibitors
- 7.2.1 Overview
- 7.2.2 Tyrosine Kinase Inhibitors: ASEAN Cancer Targeted Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.3 Immune Checkpoint Inhibitors
- 7.3.1 Overview
- 7.3.2 Immune Checkpoint Inhibitors: ASEAN Cancer Targeted Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.4 Cancer Vaccines
- 7.4.1 Overview
- 7.4.2 Cancer Vaccines: ASEAN Cancer Targeted Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.5 Gene Therapy
- 7.5.1 Overview
- 7.5.2 Gene Therapy: ASEAN Cancer Targeted Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.6 Other Therapy Types
- 7.6.1 Overview
- 7.6.2 Other Therapy Types: ASEAN Cancer Targeted Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8. ASEAN Cancer Targeted Therapy Market Analysis – by Indication
8.1 Blood Cancer
- 8.1.1 Overview
- 8.1.2 Blood Cancer: ASEAN Cancer Targeted Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Lung Cancer
- 8.2.1 Overview
- 8.2.2 Lung Cancer: ASEAN Cancer Targeted Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Breast Cancer
- 8.3.1 Overview
- 8.3.2 Breast Cancer: ASEAN Cancer Targeted Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.4 Colorectum Cancer
- 8.4.1 Overview
- 8.4.2 Colorectum Cancer: ASEAN Cancer Targeted Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.5 Prostate Cancer
- 8.5.1 Overview
- 8.5.2 Prostate Cancer: ASEAN Cancer Targeted Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.6 Stomach Cancer
- 8.6.1 Overview
- 8.6.2 Stomach Cancer: ASEAN Cancer Targeted Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.7 Cervical Cancer
- 8.7.1 Overview
- 8.7.2 Cervical Cancer: ASEAN Cancer Targeted Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.8 Liver and Intrahepatic Bile Duct Cancer
- 8.8.1 Overview
- 8.8.2 Liver and Intrahepatic Bile Duct Cancer: ASEAN Cancer Targeted Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.9 Thyroid Cancer
- 8.9.1 Overview
- 8.9.2 Thyroid Cancer: ASEAN Cancer Targeted Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.10 Other Indications
- 8.10.1 Overview
- 8.10.2 Other Indications: ASEAN Cancer Targeted Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
9. ASEAN Cancer Targeted Therapy Market Analysis – by End User
9.1 Hospital Pharmacies
- 9.1.1 Overview
- 9.1.2 Hospital Pharmacies: ASEAN Cancer Targeted Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.2 Retail Pharmacies
- 9.2.1 Overview
- 9.2.2 Retail Pharmacies: ASEAN Cancer Targeted Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.3 Online Stores
- 9.3.1 Overview
- 9.3.2 Online Stores: ASEAN Cancer Targeted Therapy Market – Revenue and Forecast, 2021-2031 (US$ Million)
10. ASEAN Cancer Targeted Therapy Market – ASEAN Analysis
10.1 Overview
10.2 ASEAN- 10.2.1 ASEAN Cancer Targeted Therapy Market Breakdown, by Key Country, 2025 and 2031 (%)
- 10.2.1.1 ASEAN Cancer Targeted Therapy Market – Revenue and Forecast Analysis – by Country
- 10.2.1.1 Indonesia: ASEAN Cancer Targeted Therapy Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.1.1 Indonesia: ASEAN Cancer Targeted Therapy Market Breakdown, by Therapy Type
- 10.2.1.1.2 Indonesia: ASEAN Cancer Targeted Therapy Market Breakdown, by Indication
- 10.2.1.1.3 Indonesia: ASEAN Cancer Targeted Therapy Market Breakdown, by End User
- 10.2.1.2 Malaysia: ASEAN Cancer Targeted Therapy Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.2.1 Malaysia: ASEAN Cancer Targeted Therapy Market Breakdown, by Therapy Type
- 10.2.1.2.2 Malaysia: ASEAN Cancer Targeted Therapy Market Breakdown, by Indication
- 10.2.1.2.3 Malaysia: ASEAN Cancer Targeted Therapy Market Breakdown, by End User
- 10.2.1.3 Philippines: ASEAN Cancer Targeted Therapy Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.3.1 Philippines: ASEAN Cancer Targeted Therapy Market Breakdown, by Therapy Type
- 10.2.1.3.2 Philippines: ASEAN Cancer Targeted Therapy Market Breakdown, by Indication
- 10.2.1.3.3 Philippines: ASEAN Cancer Targeted Therapy Market Breakdown, by End User
- 10.2.1.4 Singapore: ASEAN Cancer Targeted Therapy Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.4.1 Singapore: ASEAN Cancer Targeted Therapy Market Breakdown, by Therapy Type
- 10.2.1.4.2 Singapore: ASEAN Cancer Targeted Therapy Market Breakdown, by Indication
- 10.2.1.4.3 Singapore: ASEAN Cancer Targeted Therapy Market Breakdown, by End User
- 10.2.1.5 Thailand: ASEAN Cancer Targeted Therapy Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.5.1 Thailand: ASEAN Cancer Targeted Therapy Market Breakdown, by Therapy Type
- 10.2.1.5.2 Thailand: ASEAN Cancer Targeted Therapy Market Breakdown, by Indication
- 10.2.1.5.3 Thailand: ASEAN Cancer Targeted Therapy Market Breakdown, by End User
- 10.2.1.6 Vietnam: ASEAN Cancer Targeted Therapy Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.6.1 Vietnam: ASEAN Cancer Targeted Therapy Market Breakdown, by Therapy Type
- 10.2.1.6.2 Vietnam: ASEAN Cancer Targeted Therapy Market Breakdown, by Indication
- 10.2.1.6.3 Vietnam: ASEAN Cancer Targeted Therapy Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Astellas Pharma Inc
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Eli Lilly and Co
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Novartis AG
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Merck KGaA
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Johnson & Johnson
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 AstraZeneca
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Pfizer Inc
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Bristol Myers Squibb
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 F. Hoffmann-La Roche Ltd
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
13.11 AbbVie
- 13.11.1 Key Facts
- 13.11.2 Business Description
- 13.11.3 Products and Services
- 13.11.4 Financial Overview
- 13.11.5 SWOT Analysis
- 13.11.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations
Access the Full A Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.